7-(piperazine-1-ymethyl)-1H-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 MAP kinase inhibitors for the treatment of respiratory diseases

US8686022B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Holger Wagner · Mettenberg, DE
• Birgit Jung · Laupheim, DE
• Frank Himmelsbach · Mittelbiberach, DE
• Rolf Goeggel · Ulm, DE
• Georg Dahmann · Biberach an der Riß, DE

Key dates

• Filing date: Aug 26, 2009
• Grant date: Apr 1, 2014
• Expiry date: Jul 11, 2030

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P11/06
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention provides compounds according to general formula (I)which are proposed for the treatment of respiratory complaints, particularly asthma and COPD.